caselaw.findlaw.com/us-supreme-court/09-152.html

Case opinion for US Supreme Court BRUESEWITZ ET AL. v. ... It granted Wyeth summary judgment, holding that the relevant Pennsylvania law was preempted ...

www.americanbar.org/newsletter/publications/aba_health_esource_home/aba_health_law_esource_1104_brown.html

Bruesewitz v. Wyeth's Impact on the Vaccine Safety Debate. By Erin C. Fuse Brown1 & Jalayne J. Arias2, Public Health Law and Policy Program at Sandra Day ...

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Bruesewitz v. ... Wyeth, Inc., fka Wyeth Laboratories, et al. ... The Bruesewitzes filed a lawsuit against Wyeth in state court in Pennsylvania.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4686797

Dec 22, 2015 ... To resolve this apparent inconsistency, Wang et al. ... xylazine (10 mg/kg i.p.; Bayer Inc., Canada) and ketamine (50 mg/kg i.p.; Wyeth, Canada).

www.ncbi.nlm.nih.gov/pmc/articles/PMC4878906

Aug 1, 2010 ... Aleksandra Bortel,a Maxime Lévesque,a Giuseppe Biagini,b Jean ... However, little effort (but see Biagini et al., 2006; Klitgaard et al., ... ketamine (50 mg/kg, i.p.; Wyeth, Canada) (Martin and Kapur, 2008). .... **p<0.01 between latent period versus chronic period; LSD test after significant two-way ANOVA.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3753291

Mar 22, 2011 ... Claude-Édouard Châtillon,a,* Rina Zelmann,b Aleksandra Bortel,b .... A comparison of HFO duration versus contact size was also performed. Go to: 2. Methods. The intraperitoneal pilocarpine rat model was used (Turski et al., 1983). ... and ketamine (50 mg/kg IP: Wyeth, Canada), injected separately.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5006195

Mar 15, 2016 ... All filorexant doses (2.5/5/10/20mg) were significantly superior to placebo in ... for 4 weeks (Herring et al., 2012), almorexant (singe-dose) (Hoever et al., 2012), .... with 95% CIs provided for comparisons of treatment vs placebo. ...... Syrex, Takeda, TransOral, Wyeth, and Xenoport; has acted as a consultant ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3303220

Apr 21, 2011 ... The study by D'Anglejan-Chatillon et al. enrolled 25 men and 25 women with extracranial ..... McNeil Consumer & Specialty Pharmaceuticals, Merck, and Wyeth Consumer Healthcare; ... Vanmolkot FH, Van Bortel LM, de Hoon JN. ... Metso TM, Metso AJ, Salonen O, Haapaniemi E, Putaala J, Artto V, et al.

pdfs.semanticscholar.org/6838/163b1f2046922ecaaf62b05a515fc00970bb.pdf

Sep 23, 2010 ... described in detail in recent reviews (Esbenshade et al., 2008; Leurs ... agonism versus antagonism in the in vivo situation, thus, for the ..... including Schering ( SCH-497079), Servier (S-41150), Arena (APD916), Wyeth/Pfizer ..... Calder N, Marsilio S, Cerchio K, Declercq R, Fox-Bosetti S, Verma A, Bortel Lv, ...